NCNMGF
BIO icon

Nano-Cap New Millennium Growth Fund’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
5,000
+500
+11% +$142K 1.13% 29
2026
Q1 		$1.25M Buy
4,500
+1,750
+64% +$504K 1.17% 27
2025
Q4 		$833K Buy
+2,750
New +$858K 0.71% 55

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's BIO Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q2 2026, buying an estimated $142K and bringing the position to 5,000 shares worth $1.47M. The position accounts for 1.13% of the portfolio, ranked #29.

Nano-Cap New Millennium Growth Fund first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 5,000 shares of Bio-Rad Laboratories Class A worth $1.47M as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 500 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $142K.
  • Bio-Rad Laboratories Class A made up 1.13% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #29 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.